Stay updated on Ertugliflozin in Pediatric T2DM Clinical Trial
Sign up to get notified when there's something new on the Ertugliflozin in Pediatric T2DM Clinical Trial page.

Latest updates to the Ertugliflozin in Pediatric T2DM Clinical Trial page
- Check5 days agoChange DetectedA new revision entry v3.3.2 was added to the history, and the prior revision v3.3.1 was removed.SummaryDifference0.0%

- Check13 days agoChange DetectedRevision: v3.3.1 was added and Revision: v3.2.0 was removed; this change affects only the page's revision label in the footer and does not alter trial data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedDeleted a general operating-status notice about government funding and NIH/OPM updates. The core study details and history on the page remain unchanged.SummaryDifference0.2%

- Check34 days agoChange DetectedRecord History shows a 2025-10-31 update with Results Posted and related data (Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow) and an updated Study Status. The prior 2025-05-29 entry 'Results Submitted' was removed.SummaryDifference0.3%

- Check56 days agoChange DetectedAdded a comprehensive study record block (identification, design, measures, eligibility, flows, results, adverse events, quality control) with a returned date; significant for pages that track research studies, but no changes to existing content were removed.SummaryDifference3%

- Check63 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference7%

Stay in the know with updates to Ertugliflozin in Pediatric T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ertugliflozin in Pediatric T2DM Clinical Trial page.